Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin for immune restoration in hospitalized patients with decompensated cirrhosis
ISRCTN14174793Phase 3Completed
- Sponsor
- University College London
- Start
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, open-label trial of albumin (human) in Cirrhosis (3 arms), sponsored by University College London. Primary endpoints: Daily serum albumin level and Composite of nosocomial infection, renal dysfunction, or mortality. Started Apr 2015; status: completed.
02
Drugs
albumin (human)
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on ISRCTN14174793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14174793.